About Elysia
Elysia is a Healthcare company based in New York (United States) founded in 2014 by Bruce Wang and Wes Furnback, and was acquired by W2O Group in September 2020. Health economics consulting and database analysis are provided by Elysia. It operates on a Professional Services model. Its chief executive, as recorded, is Bruce Wang. Elysia offers products and services including Health Economic Modeling, Database Analysis, Market Access, and Literature Searches. Its focus areas include Health Economics and Consulting Services. Its legal entity is Elysia Group, LLC. Its competitors include Target RWE, Secura Bio and Hylant; 1 of its 3 listed competitors has raised funding.
Company details
Health economics consulting and database analysis are delivered by Elysia across Asia and the United States. Focus is placed on bridging gaps between commercial and health economic teams through rigorous academic approaches. Solutions such as cost-effectiveness models, budget impact models, and market access strategies are developed. Specialized services in database analysis, particularly with Taiwans National Health Insurance Research Database, are offered. Literature searches to understand trends and support organizational queries are also conducted.
- Headquarters New York, United States
- Founders Bruce Wang, Wes Furnback
- Stage Acquired
- SectorsHealthcare
- Website elysiagroup.com
- Acquired by W2O Group (Sep 2020)
- Legal Name Elysia Group, Llc
Products & Services of Elysia
Elysia offers a comprehensive portfolio of products and services, including Health Economic Modeling, Database Analysis, Market Access, and Literature Searches.
Models for cost-effectiveness and budget impact are provided.
Global database analyses are conducted for health research.
Support for launching innovative technologies is strategically offered.
Comprehensive literature searches are performed for trend analysis.
Investors in Elysia
Elysia has secured backing from 1 investor. Prominent investors backing the company include W2O Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Marketing communications services are delivered to businesses worldwide. | 2001 | w2ogroup.com | New York, United States |
Investor details for Elysia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Elysia
2 people are tracked at Elysia (2 in leadership).
| Name | Role | Group |
|---|---|---|
Bruce Wang | Co-Founder & CEO | Leadership |
Wes Furnback | Co-Founder & President | Leadership |
Complete people profiles for Elysia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Elysia
2 dated milestones of Elysia across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Elysia is founded.
- Exit Acquired by W2O Group.
Competitors of Elysia
Elysia has 3 listed competitors in our database, 1 of them funded. They include Target RWE, Secura Bio and Hylant.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| targetrwe.com | 2017 | Durham, United States | 116 | Marketing services to the pharmaceutical industry are provided. | ||
| securabio.com | 2018 | Henderson, United States | $55M | Consulting services for market access and health outcomes are provided. | ||
| hylant.com | 1935 | Toledo, United States | 849 | Offers business insurance, employee benefits, and risk consulting services worldwide. |
Detailed competitors of Elysia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Elysia (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Elysia
Complete news archive for Elysia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elysia
Elysia was founded in 2014.
Elysia is headquartered in New York, United States. It is registered at New York, New York, United States.
Bruce Wang is the CEO of Elysia, as recorded in our data. They have also founded this company.
Health economics consulting and database analysis are delivered by Elysia across Asia and the United States. Focus is placed on bridging gaps between commercial and health economic teams through rigorous academic approaches. Solutions such as cost-effectiveness models, budget impact models, and market access strategies are developed. Specialized services in database analysis, particularly with Taiwans National Health Insurance Research Database, are offered. Literature searches to understand trends and support organizational queries are also conducted.
Elysia's top competitors include Target RWE, Secura Bio and Hylant.
Elysia offers Health Economic Modeling, Database Analysis, Market Access, and Literature Searches.
Elysia has 1 investor. Key investors include W2O Group.
Elysia operates through Elysia Group, Llc.
Yes. Elysia was acquired by W2O Group in September 2020.